Alexa Dessy is a Neurology physician. OpenAlex indexes 15 publications with 394 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1101 Chestnut St Fl 10
Philadelphia, PA 191073612
Telephone
215-955-6000Provider last certified this registry record 2 Jan 2025.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Boston Scientific CorporationProgram year20252 payments
- Medtronic, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
89.3%Aromatic Amino Acid Decarboxylation Inhibitor49.3%Carbidopa-Levodopa79%Carbidopa-Levodopa Er17%Rytary4%Part D<11 patientsSSRI5.8%Escitalopram Oxalate67%Sertraline Hcl33%Part D<11 patients+ 11 more classes in this area
Cardiovascular
7.9%Beta blocker7.9%Propranolol Hcl68%Propranolol Hcl Er32%Part D<11 patientsMetabolism & gastrointestinal
2.9%Anticholinergic2.9%Atropine Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Non-Pharmacologic Interventions for Hispanic Caregivers of Persons with Dementia: Systematic Review and Meta-Analysis
Journal of Alzheimer s Disease
2022 - A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
Journal of the Neurological Sciences
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”